Investor relations

We're speaking with angels, venture funds and corporate investors. If you believe hearing care deserves better software, we'd like to meet you.

See the product

Why now

Demand is rising, the tools haven't moved

~1.5 billion

people worldwide live with some degree of hearing loss.

Source: World Health Organization

Super-aged

More than one in five people in Taiwan are 65 or older; Japan and Korea are on the same curve.

Source: National Development Council, Taiwan

~1.37 million

people with hearing loss in Taiwan — and fitting and follow-up still run on paper, spreadsheets and systems that don't talk.

Source: SEER SONUS Taiwan market research

Who we're talking to

Angels, VCs and corporate investors

Angel

Angel investors

Operators and founders from healthcare, retail and SaaS — bringing experience and the first key introductions along with capital.

  • Hearing-care or healthcare channel experience
  • B2B SaaS operating experience
VC

Venture capital

Funds focused on vertical SaaS, health tech or applied AI that can back us from Taiwan into Asia-Pacific.

  • A vertical SaaS / health-tech portfolio
  • An Asia-Pacific network
CVC

Corporate investors

Investment arms of hearing-aid makers and distributors, healthcare groups and technology companies — taking the system into more stores together.

  • Channels and store networks
  • Complementary products or technology
NVIDIA Inception Program

NVIDIA Inception Program

SEER SONUS™ is a member of NVIDIA Inception

NVIDIA's program for AI startups, offering technical resources and a global ecosystem.

Learn about NVIDIA Inception

Contact investor relations

When you write, please include:

  • Your firm or name, and type (angel / VC / corporate)
  • Stage focus and typical cheque size
  • Why hearing care or vertical AI interests you
  • What you'd like to learn first

We'll reply and arrange a conversation with the founders.

Let's talk about what's next in hearing care

Write to us and we'll set up a conversation with the founders.

This page is for information only and is not an offer or solicitation to buy or sell any security, nor investment advice.